Hey Mate, I think the answer to your question can be found in this paragraph.
The ability to treat difficult-to-access tumor's, such as pancreatic and liver cancers, by delivering CF33 trans-arterially may be valuable to cancer patients compared to traditional administration methods where dense fibrous tissue and lack of blood vessels supplying the tumor's have been shown to limit therapy uptake.
Reading this paragraph suggests to me that the issue is that fibrous tissue and lack of blood vessels obviously inhibits and restricts the effectiveness of CF33 to access the tumor, so by a delivering it Trans-arterially rather than conventional/traditional methods it will pack a lot more punch.
Looks like a great partnership to me.
- Forums
- ASX - By Stock
- Ann: Imugene and RenovoRx CF33 Virotherapy Delivery Collaboration
Hey Mate, I think the answer to your question can be found in...
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $424.5M |
Open | High | Low | Value | Volume |
5.8¢ | 5.8¢ | 5.6¢ | $1.032M | 18.08M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 90000 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 744737 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 90000 | 0.057 |
10 | 1292446 | 0.056 |
31 | 2801064 | 0.055 |
7 | 854500 | 0.054 |
12 | 693196 | 0.053 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 299151 | 3 |
0.059 | 528777 | 3 |
0.060 | 392948 | 5 |
0.061 | 176830 | 3 |
0.062 | 152014 | 3 |
Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
Last
5.8¢ |
  |
Change
0.000 ( 1.03 %) |
|||
Open | High | Low | Volume | ||
5.8¢ | 5.8¢ | 5.6¢ | 4924782 | ||
Last updated 15.59pm 14/06/2024 ? |
Featured News
IMU (ASX) Chart |